Page 2 - Patanjali Ayurved

Sebi's higher float proposal for IBC firms could run into hurdles

Several legal experts plan to highlight the challenges in implementing all three options recommended by the regulator

Madras HC stays order barring Patanjali Ayurved from using mark 'Coronil'

Division Bench grants the company relief for two weeks

BS READS: The mystery investor who made a killing in Ruchi Soya

A Delhi-based company put Rs 13 cr for a 5.94% stake in Ruchi Soya soon after it got relisted; today that investment is worth Rs 1,500 crore

Madras High Court restrains Patanjali from using trademark 'Coronil'

Justice Karthikeyan passed the order valid till July 30 on the plea of Chennai-based company Arudra Engineering Private Limited

From Patanjali's claim to U-turn on Coronil: Sequence of events

On June 23, Baba Ramdev-led Patanjali Ayurved launched a medicine, 'Coronil', for treating Covid-19 in just seven days

Top Headlines: Relief for pharma cos, ban to hit Chinese firms, and more

Here are the top headlines on Wednesday morning

Patanjali takes a u-turn; says never claimed to have made Covid-19 medicine

The Haridwar-based organisation has withdrawn from its earlier claim, in reply to the notice given by Uttarakhand Ayush Ministry

Ruchi Soya soared 90 times in 5 months; should you buy?

From Rs 16.9 to Rs 1,519 in five months, the stock has seen a spectacular rise of 8,988 per cent

Covid updates: Nearly 20k cases in 24 hrs in India, World tally tops 10 mn

In his monthly address 'Mann Ki Baat' today, Prime Minister Narendra Modi asked people to be more careful during the 'unlock' period

Notice sent to NIMS Jaipur for unauthorised trials of Patanjali's Coronil

The Rajasthan government has clarified that the drug cannot be used as a medicine in the state without the permission of the Ministry of AYUSH

Coronavirus updates: Over 17,000 new cases, record recoveries in India

India death toll crosses 15,000; Maharashtra, Delhi, Tamil Nadu account for 68% of cases added today

Will take action against sale of Patanjali Covid-19 drug in Rajasthan: Govt

Neither has anyone applied to the state government nor has the state government given any permission in this regard, State Health Minister Raghu Sharma said

Patanjali Ayurved submits report on its Covid-19 drug to Ayush ministry

"Baba Ramdev has produced a new medicine. Whatever research they have done, it should come to the Ayush Ministry for authentication," Naik said

India-US 'green' corridor for air travel, and other coronavirus updates

The total number of Covid-19 cases in Delhi crossed the 66,000 mark, with the biggest single-day spike of 3,947 fresh infections being reported on Tuesday

Good that Ramdev has given Covid-19 medicine, but rules matter: Minister

The Ministry had also issued a notification in April stating the requirements and the manner in which the research studies on Covid-19 with AYUSH interventions/medicines should be undertaken

Govt asks Ramdev's Patanjali group to stop Covid-19 drug ads, seeks details

Hours after the launch, the ministry denied knowledge of the drugs and asked the group to refrain from publicising them.

Patanjali announces Covid-19 medicine; govt frowns and asks for details

Patanjali has also been asked for details of the sample size, sites and hospitals where the research study was conducted

India tally rises to 440K; Patanjali launches ayurvedic drug for Covid-19

According to government data, the situation in India is not as alarming as some of the other countries, given a limited spread on a per-capita basis

Patanjali's Rs 250 crore NCD subscribed within three minutes of opening

The fund-raising will be used to meet the Haridwar-based company's working capital requirements and strengthen the supply chain network

Top 10 biz headlines: Boeing cuts 12,000 jobs, SBI slashes FD rate and more

Here are the top 10 headlines on Thursday morning